'adults developed'

Alafevir EM Tablet is an antiviral medication primarily prescribed for the treatment of chronic hepatitis B virus (HBV) infection in adults. Developed and manufactured by the pharmaceutical company Gilead Sciences, Alafevir EM Tablet is notable for its active ingredient, tenofovir alafenamide. This compound plays a crucial role in managing the replication of the hepatitis B virus, thus helping to control the infection and its associated complications.

Glycitop 60mg Tablet MR is a medicine used to treat type 2 diabetes mellitus in adults. It belongs to a group of medicines called sulfonylureas and helps control blood sugar levels in people with diabetes. This helps to prevent serious complications of diabetes like kidney damage and blindness.

Glycitop-MR 30 Tablet is a medicine used to treat type 2 diabetes mellitus in adults. It belongs to a group of medicines called sulfonylureas and helps control blood sugar levels in people with diabetes. This helps prevent serious complications of diabetes.

Glycitop 60mg Tablet MR is a medicine used to treat type 2 diabetes mellitus in adults. It belongs to a group of medicines called sulfonylureas and helps control blood sugar levels in people with diabetes. This helps to prevent serious complications of diabetes like kidney damage and blindness.

Glycitop 80mg Tablet is a medicine used to treat type 2 diabetes mellitus in adults. It belongs to a group of medicines called sulfonylureas and helps control blood sugar levels in people with diabetes. This helps to prevent serious complications of diabetes like kidney damage and blindness.

To treat anaemia, the usual dose for adults and children over 1 year old is 5mg, taken once a day. Sometimes the dose is increased to 15mg a day. If your child is under 12 months old, the doctor will use your child's weight to work out the right dose.

To control blood sugar levels in adults with type 2 diabetes. The combination medication helps to lower blood sugar by targeting different mechanisms within the body.

Empagliflozin 25mg and Linagliptin 5mg tablets (Glyxambi) are used to improve blood sugar control in adults with type 2 diabetes, often used alongside diet and exercise, and may also reduce the risk of death from heart problems in those with type 2 diabetes and cardiovascular disease.

Empagliflozin 10 mg and Linagliptin 5 mg tablets, sold as Glyxambi, are used to improve blood sugar control in adults with type 2 diabetes, often as an adjunct to diet and exercise, and can also help reduce the risk of cardiovascular death in those with existing heart disease